Perspective Therapeutics, Inc.CATXNYSE
Loading
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q4 2025 | -44.36% |
| Q3 2025 | -20.87% |
| Q2 2025 | -18.20% |
| Q1 2025 | 54.75% |
| Q4 2024 | -165.63% |
| Q3 2024 | -29.20% |
| Q2 2024 | 4.72% |
| Q1 2024 | 50.22% |
| Q4 2023 | -138.27% |
| Q3 2023 | 6.75% |
| Q2 2023 | -2893.53% |
| Q1 2023 | 83.13% |
| Q4 2022 | 44.02% |
| Q3 2022 | -95.13% |
| Q2 2022 | -66.78% |
| Q1 2022 | 24.75% |
| Q4 2021 | 28.49% |
| Q3 2021 | -111.40% |
| Q2 2021 | -42.42% |
| Q1 2021 | 14.17% |
| Q4 2020 | -21.74% |
| Q3 2020 | 39.98% |
| Q2 2020 | -117.98% |
| Q1 2020 | 39.24% |
| Q4 2019 | -9.93% |
| Q3 2019 | 25.48% |
| Q2 2019 | 2.84% |
| Q1 2019 | 20.30% |
| Q4 2018 | 6.23% |
| Q3 2018 | 36.05% |
| Q2 2018 | -77.03% |
| Q1 2018 | 8.95% |
| Q4 2017 | 5.37% |
| Q3 2017 | 16.61% |
| Q2 2017 | -36.32% |
| Q1 2017 | 6.21% |
| Q4 2016 | 3.20% |
| Q3 2016 | -26.43% |
| Q2 2016 | 0.88% |
| Q1 2016 | 8.87% |